Searched for
SYSTEMATIX SHARES
Why Systematix is bullish on Apollo Micro Systems after 47% YTD rally; check target priceSystematix initiated coverage of Apollo Micro Systems with a Buy rating and Rs 570 target, citing defence-system integration, a Rs 12,000-c...- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Systematix initiates coverage on 5 affordable housing finance stocks; sees up to 48% upsideSystematix Research has initiated coverage of five affordable housing finance companies with Buy ratings, seeing 28-48% upside from current...
- ESDS Software raises Rs 216 crore from anchor investors ahead of IPO; Quant MF among top buyersESDS Software Solution raised Rs 216 crore from anchor investors ahead of its Rs 720 crore IPO, opening August 28. Priced at Rs 408-429, th...
- A91 Partners and Sixth Sense-backed Pushp Brand gets SEBI nod for IPO, to offer 74.45 lakh shares via OFSPushp Brand, backed by A91 Partners and Sixth Sense, has received SEBI approval for its IPO, comprising an OFS of up to 74.45 lakh shares. ...
- Systematix initiates coverage on Timex Group India with Buy rating. Check target priceSystematix has initiated coverage on Timex Group India with a Buy rating and a target price of Rs 820, implying around 30% upside. The brok...
- Global Market: Porsche stock falls as MHP sale, weak revenue keep investors on edgePorsche shares faced pressure as investors assessed its €320 million MHP sale to TCS and a €1.25 billion technology partnership. The deal s...
- Vedanta Aluminium shares rise 2% as firm expands automotive portfolio with two advanced alloys. What’s ahead?Vedanta Aluminium Metal shares gained more than 2% after the company launched two advanced offerings under its Primary Foundry Alloy range ...
- ICICI Bank overtakes HDFC Bank as top MF holding in July amid governance concernsICICI Bank now leads mutual fund portfolios, surpassing HDFC Bank in July. This shift reflects investor concerns over HDFC Bank's leadershi...
- NBFCs outpace banks in June as cards lose some creditNBFCs outpaced banks in retail lending growth in June, with loans rising over 20% year-on-year compared with 16% for banks. Growth was driv...
- ETMarkets NRI Talk| The question is no longer 'Why India?' but 'At what valuation?': Bhaskar HazraHazra also shares his views on sector opportunities, the role of alternatives, and why financial assets are increasingly becoming a preferr...
- Vedanta Aluminium shares can rally up to 28%? Why Systematix initiated coverage on the stockVedanta Aluminium shares: Systematix Institutional Equities initiated coverage on Vedanta Aluminium with a Buy rating and a target price of...
- FIIs increase PSU exposure, trim stakes in private banksForeign investors reduced holdings in top private banks over the past year. They increased stakes in select public sector lenders, showing ...
- Master Chains N Jewels files IPO papers with Sebi; eyes Rs 400 cr via fresh issueMaster Chains N Jewels Ltd has filed preliminary papers for an initial public offering. The proposed IPO includes a fresh issue of equity s...
- Bank of Baroda shares fall 2% after Q1 earnings. Why are brokerages slashing target prices?Bank of Baroda shares fell after a sharp 72% drop in Q1 net profit due to a one-off NMC Health settlement. Brokerages cut target prices des...
- Bluestone Jewellery shares rocket 36% in just three days after Q1 results. Can the momentum sustain?BlueStone Jewellery shares have surged 36% in three trading sessions after the company's strong Q1 results, which marked a return to profit...
- Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practicalUS President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...
- Dr Reddy’s shares crack 9% after weak Q1; these 3 brokerages slash their target pricesDr Reddy’s shares plunged 9% on Thursday after the drugmaker reported a weak Q1 FY27 performance, with net profit tumbling 69% year-on-year...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- BlueStone Jewellery shares soar 29% in 2 days after stellar Q1 show. Should you buy, sell or hold the stock?BlueStone Jewellery shares have surged nearly 29% in two sessions after the company swung to profit in Q1 FY27 and delivered strong revenue...
Load More
